14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.31 $4.00 Friday, 3rd May 2024 CYCC stock ended at $2.00. This is 19.68% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 28.15% from a day low at $1.94 to a day high of $2.48.
90 days $1.31 $4.00
52 weeks $1.31 $13.20

Historical Cyclacel Pharmaceuticals prices

Date Open High Low Close Volume
Mar 30, 2023 $8.55 $9.26 $8.55 $8.89 8 003
Mar 29, 2023 $9.27 $9.27 $8.55 $8.55 1 392
Mar 28, 2023 $8.70 $8.88 $8.42 $8.55 2 049
Mar 27, 2023 $9.13 $9.15 $8.56 $8.63 2 300
Mar 24, 2023 $8.57 $9.35 $8.42 $8.99 5 962
Mar 23, 2023 $8.42 $9.15 $8.42 $8.85 1 074
Mar 22, 2023 $9.00 $9.49 $8.40 $8.42 2 312
Mar 21, 2023 $8.85 $9.74 $8.55 $9.00 4 701
Mar 20, 2023 $9.30 $9.78 $9.00 $9.00 1 554
Mar 17, 2023 $9.23 $9.78 $9.00 $9.78 3 115
Mar 16, 2023 $9.30 $9.78 $9.03 $9.15 798
Mar 15, 2023 $9.15 $9.74 $9.15 $9.23 978
Mar 14, 2023 $9.53 $9.80 $9.00 $9.45 6 019
Mar 13, 2023 $9.65 $10.60 $9.15 $9.54 4 836
Mar 10, 2023 $10.50 $11.09 $9.45 $9.80 5 458
Mar 09, 2023 $11.50 $11.85 $10.55 $10.80 3 277
Mar 08, 2023 $10.65 $11.40 $10.60 $10.95 3 775
Mar 07, 2023 $11.40 $11.40 $10.35 $10.93 5 852
Mar 06, 2023 $11.70 $11.88 $10.68 $11.23 2 430
Mar 03, 2023 $12.46 $12.46 $11.40 $11.55 7 376
Mar 02, 2023 $12.71 $12.71 $11.40 $12.10 3 319
Mar 01, 2023 $12.75 $13.31 $11.55 $11.58 3 798
Feb 28, 2023 $12.60 $13.65 $12.33 $12.60 3 799
Feb 27, 2023 $13.35 $13.49 $12.60 $12.63 7 522
Feb 24, 2023 $13.80 $14.85 $13.65 $13.85 2 204
Click to get the best stock tips daily for free!

About Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-... CYCC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT